Boron Biologicals Inc. (BBI) received a $50,000 small businessinnovation research grant from the National Institutes ofHealth (NIH) to develop enzyme inhibitors that couldeventually shut down virus functions. BBI research may haveimplications for the treatment of viral infections such as herpesand HIV, and cancer.
BBI of Raleigh, N.C., was founded in 1986 to promotecommercial development of a proprietary class of compoundsbased on boron that can have key applications in drugs,agriculture and veterinary medicine.
(c) 1997 American Health Consultants. All rights reserved.